Skip to content

Randomized clinical trial comparing different implant timing protocols following alveolar ridge preservation (ARP)

Randomized clinical trial comparing different implant timing protocols following alveolar ridge preservation (ARP) - ARP/ Early vs Delayed

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00035032
Enrollment
32
Registered
2024-10-23
Start date
2025-04-08
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Missing tooth

Interventions

Group 1: SPI® NEVO RC INICELL®, dental implant placement 8 weeks after tooth extraction with alveolar ridge preservation. Group 2: SPI® NEVO RC INICELL®, dental implant placement 6 months after tooth

Sponsors

University of Zurich Center of Dental Medicine Clinic of Reconstructive Dentistry
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: - >18 years of age - Systemically healthy patients - Requiring extraction of at least one upper or lower asymptomatic front tooth or premolar - Presence of at least one neigboring tooth - Bleeding on probing <20% - Plaque index <20% - Capability to comply with the study procedures - Signed Informed Consent Form

Exclusion criteria

Exclusion criteria: - > 80 years of age - Pregnant or lactating women - Skeletal immaturity - Known or suspected non-compliance, drug or alcohol abuse - Smokers (>20 cigarettes/day) - Buccal bony dehiscences up to 50% - Currently taking drugs that influence bone metabolism - History of malignancy, radiotherapy or chemotherapy for malignancy in the past 5 years - Untreated periodontitis - General medical contraindication for implant surgery

Design outcomes

Primary

MeasureTime frame
The primary outcome of this study will be the difficulty of dental implant placement assessed by the clinician.

Secondary

MeasureTime frame
Clinical biological outcomes (probing depth (PD), marginal bleeding index (MBI), plaque index (PI), patient’s PICF, and saliva, and radiographic evaluations (marginal bone levels (MBL)), prophilometric measurements, experience of the clinician (years), impant insertion torque and PES will be avaluated at different timepoints.

Countries

Switzerland

Contacts

Public ContactStefan Bienz

University of Zurich Center of Dental Medicine Clinic of Reconstructive Dentistry

stefan.bienz@zzm.uzh.ch+41 44 634 04 04

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026